Purchase Order HHSN272201601160P

Award Date 8/23/16
Potential Completion Date 8/26/16
Potential Value $11K
Ultimate Awardee
Not listed
PSC Category
6810 - Chemicals
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Westlake, MD 20817, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $24,920.00 firm fixed-price purchase order contract to ABI Scientific Inc., a minority-owned and Asian-Pacific American-owned for-profit organization. The contract was awarded on September 24, 2018, with a completion date of October 24, 2018, and the place of performance is Bethesda, Maryland. This contract does not have a set-aside designation.
<p>This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to ABI Scientific Inc. for the procurement of chemical supplies. The contract, awarded on April 7, 2016, has a firm fixed price of $12,405.00 and an ultimate completion date of May 7, 2016. The contract is not associated with a set-aside program. ABI Scientific Inc. is a minority-owned, Asian-Pacific American-owned, for-profit organization.</p>
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order contract to ABI Scientific Inc., a minority-owned and Asian-Pacific American-owned for-profit organization. The contract is for the delivery of 100 units of Adherent Cell Expression Media 250 ML at a total potential value of $12,340.00. The contract was awarded on January 30, 2018, with a completion date of January 30, 2019....
The federal contract award, HHSN272201600008I|HHSN27200001, was granted by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The contract is for $4,669,061.95 and is for quality assurance/quality control (QA/QC) services in support of the NIAID's Comprehensive Resources for HIV Microbicides and Biomedical Prevention...
This federal contract award, identified as HHSN272201501390P, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services. The $6,130.60 firm-fixed-price purchase order was awarded to Invivogen, a for-profit organization, on September 23, 2015 for the product &quot;AMBIS 1755049 ODN1826, 5MG; PRODUCT ID TLRL-1826-5.&quot; The contract did not have a set-aside designation and is scheduled for completion on...
This federal contract award, valued at $2,959,434.41, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL). The contract is for the synthesis and production of an HIV-1 envelope glycopeptide immunogen nanoparticle vaccine as part of NIAID's Preclinical Development Support program. This is a cost-plus-fixed-fee delivery order contract with an ultimate...
This federal contract award, valued at $1,469,410.09, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the Department of Health and Human Services (HHS). The contract was awarded to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods and a leading contract research and manufacturing organization specializing in the development of gene therapies, vaccines, oncolytics, and immunotherapies. The contract is for NIAID...
This federal contract award, with ID HHSN272201600252P, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $4,480.00, was awarded to Affymetrix, Inc., a for-profit manufacturer of goods, for the procurement of AMBIS 1771616 PROCARTAPLEX HUMAN CYTOKINE products. The contract was awarded on a firm-fixed price basis with a completion date of February 13, 2016. The...
This federal contract award, valued at $572,349.48, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The contract is for material receipt, storage, shipping, and inventory services to support NIAID's Comprehensive Resources for HIV Microbicides and Biomedical Prevention program. This is a Delivery Order under ABL's existing...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Advanced Bioscience Laboratories, Inc. (ABL), a leading contract research and manufacturing organization. The $548,977.00 cost-plus-fixed-fee contract is for the delivery of services in support of NIAID's infectious disease research and product development initiatives. This award is a task order under an existing Indefinite...

The federal contract award HHSN272201601160P was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to ABI Scientific Inc. for the product KIFUNENSINE. The $11,280.00 firm fixed price purchase order has an ultimate completion date of August 26, 2016. This contract was set aside for a small business, and ABI Scientific Inc. is a minority-owned, for-profit Asian-Pacific American organization.

Generated 11/24/24, 9:33 AM